Drugs / young plasma
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02968433 | Nov 2016 → Dec 2019 | Parkinson disease | Stanford University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | young plasma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02968433 ↗ |
| Route | Intravenous | “Intravenously-Administered Plasma” NCT02968433 ↗ |